PATENT CLAIM ANALYSIS

Application Number: 16252648
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-05
Patent Classification: ["514", "017600"]

Abstract:
Prodrugs of an NMDA antagonist, (S)-1-phenyl-2-(pyridin-2-yl)ethanamine, useful for the treatment of depression (particularly major depressive disorder) or pain; compositions comprising them, and methods of making them.

Claim (Index 22):
The pharmaceutical composition of  claim 19  wherein the carrier is selected from lactose, saccharose, sorbitol, mannitol; a starch, and a cellulose derivative.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 99.0
- Lexical Diversity: 1.29032
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15034727', '15785654', '15194984', '11977777', '13722740']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7255815576668457
- 35 USC 102 Novelty (BERT): 0.5462344810051537
- Combined Prediction Score: 0.7076468500006765
- Mean Citation Score: 271.861012
- Max Citation Score: 385.91602
- Similarity Product: 193.6220429161501

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test